Dr. Monsul is CEO and co-founder of Quorum Innovations, a microbiome therapeutics discovery company in Sarasota, FL. He was recently awarded his 9th patent from the USPTO in the field of microbiome therapeutics. He is a frequent presenter at microbiome conferences on the topic of commensal biofilms, skin barrier health, the functional microbiome and was recently was awarded a DARPA Grant. Dr. Monsul graduated from Drexel University and completed surgical training at Yale University School of Medicine and The Johns Hopkins Hospital, where he later remained on faculty. His focus is on the translation of human microbiome research into clinically relevant technologies.